KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $3.4 billion.

  • Elevance Health's Other Non-Current Liabilities rose 165.36% to $3.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.4 billion, marking a year-over-year increase of 165.36%. This contributed to the annual value of $3.4 billion for FY2025, which is 165.36% up from last year.
  • Elevance Health's Other Non-Current Liabilities amounted to $3.4 billion in Q4 2025, which was up 165.36% from $4.1 billion recorded in Q3 2025.
  • Over the past 5 years, Elevance Health's Other Non-Current Liabilities peaked at $4.1 billion during Q3 2025, and registered a low of $1.6 billion during Q4 2022.
  • In the last 5 years, Elevance Health's Other Non-Current Liabilities had a median value of $1.9 billion in 2021 and averaged $2.4 billion.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 936.33% in 2022, then surged by 10932.91% in 2025.
  • Quarter analysis of 5 years shows Elevance Health's Other Non-Current Liabilities stood at $1.7 billion in 2021, then decreased by 7.19% to $1.6 billion in 2022, then grew by 11.27% to $1.7 billion in 2023, then soared by 91.37% to $3.3 billion in 2024, then increased by 1.65% to $3.4 billion in 2025.
  • Its Other Non-Current Liabilities stands at $3.4 billion for Q4 2025, versus $4.1 billion for Q3 2025 and $3.9 billion for Q2 2025.